Multiple Sclerosis Clinical Trials

Showing 2461-2480 of 2,839 trials

Effect of Glycopyrrolate and Atropine on Catheter-Related Bladder Discomfort

NCT02228473

We want to evaluate the efficacy of the glycopyrrolate and atropine for the prevention of catheter-related bladder discomfort.

Catheter Site DiscomfortComplicationsAnesthesia+1 more

Seoul National University Hospital76 participantsStarted Sep 2014

Seoul, Korea, Republic of, South Korea

UNKNOWNPhase 1/2

Efficacy, Safety and Tolerability of Andrographolides Versus Placebo in Patients With Progressive Forms of MS

NCT02273635

The purpose of this study is to compare the efficacy and safety of andrographolide 140 mg administered twice a day orally versus a placebo as a modifying treatment of the disease in patients with the progressive forms of Multiple Sclerosis (MS). The principal outcome is to determine the efficacy, of andrographolide in retarding the progression of brain atrophy in patients with progressive forms of MS.

Primary Progressive Multiple SclerosisMultiple Sclerosis, Secondary Progressive

Innobioscience SpA68 participantsStarted Sep 2014

Santiago, Santiago Metropolitan, Chile

COMPLETEDPhase 3

Randomized Study With Oxaliplatin in 2nd Line Pancreatic Cancer

NCT01121848

Primary Objective: To demonstrate that the addition of oxaliplatin to 5-Fluorouracil (5-FU) and Leucovorin (LV) will improve the Progression-Free Survival (PFS). Progression is based on RECIST (Response Evaluation Criteria In Solid Tumors) criteria or death Secondary Objective: To evaluate other measures of tumor responses, safety, quality of life (QoL), and health utility assessment.

Pancreatic Neoplasms

Sanofi108 participantsStarted Jul 2010

Abbotsford, Canada • Brampton, Canada • Burnaby, Canada +12 more locations

Effect of Glycopyrrolate and Atropine on Catheter-Related Bladder Discomfort

Efficacy, Safety and Tolerability of Andrographolides Versus Placebo in Patients With Progressive Forms of MS

Randomized Study With Oxaliplatin in 2nd Line Pancreatic Cancer

Related Searches

Mannitol Brain Relaxation Effect

Ruptured Aorta-iliac Aneurysms: Endo vs. Surgery

Temsirolimus to Reverse Androgen Insensitivity for Castration-resistant Prostate Cancer

Hyperthermia Treatment in Conjunction With Mitomycin C Versus Bacillus Calmette-Guérin Immunotherapy (BCG) for Superficial Bladder Cancer

Treatment of Chronic Wound Biofilms

Sevoflurane Versus Desflurane for Catheter-related Bladder Discomfort

Accuracy of FDG-PET Scanning to Diagnose Malignant Thyroid Nodules

A Study of Lapatinib in Combination With Everolimus in Patients With Advanced, Triple Negative Breast Cancer

Study of FLOMAX® Versus Placebo in Female Patients With Lower Urinary Tract Symptoms (LUTS) With a Significant Component of Voiding Symptoms

THE USE OF N-ACETYLCYSTEINE ATTENUATING CISPLATIN-INDUCED TOXICITIES BY OXIDATIVE STRESS

Brain Functional Connectivity Changes Following Cognitive Rehabilitation in Multiple Sclerosis: an fMRI Study

Radical Cystectomy, Nutrition and Convalescence

Randomized Anastrozole Exercise Trial

Betaferon® Regulatory Post-Marketing Surveillance

Tykerb Evaluation After Chemotherapy (TEACH): Lapatinib Versus Placebo In Women With Early-Stage Breast Cancer

Dose-finding Study of BI 2536 Administered in Combination With Gemcitabine in Patients With Locally Advanced or Metastatic Pancreatic Cancer

Disease Control and Safety in Patients With Relapsing Remitting Multiple Sclerosis (RRMS) Switching From Natalizumab to Fingolimod